Carole Ben-Maimon
President and CEO at Larimar Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Larimar Therapeutics Inc., 3 years.
Larimar Therapeutics Inc.
Director · President and CEO
Chief executive roles
Larimar Therapeutics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 26, 2026 | Larimar Therapeutics Inc. | Grant or award | +100,100 | — | — |
| Jan 22, 2025 | Larimar Therapeutics Inc. | Grant or award | +91,000 | — | — |
| Jan 17, 2024 | Larimar Therapeutics Inc. | Grant or award | +66,125 | — | — |
| May 17, 2023 | Larimar Therapeutics Inc. | Open-market purchase | +5,000 | $3.71 | $18,550 |
| Jan 31, 2023 | Larimar Therapeutics Inc. | Grant or award | +205,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.